AxoGen Inc. [NASDAQ: AXGN] gained 4.46% or 0.56 points to close at $13.12 with a heavy trading volume of 1248646 shares. The company report on August 31, 2020 that Axogen, Inc. to Present at the Cantor Virtual Global Healthcare Conference.
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that Karen Zaderej, chairman, CEO, and president will present at the Cantor Virtual Global Healthcare Conference. The virtual presentation is scheduled for Wednesday, September 16, 2020 at 1:20 p.m. ET.
The presentation will be webcast live and can be accessed through the Investors page at www.axogeninc.com. For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.axogeninc.com.
It opened the trading session at $12.67, the shares rose to $13.87 and dropped to $12.60, the range by which the price of stock traded the whole day. The daily chart for AXGN points out that the company has recorded 56.56% gains over the past six months. However, it is still -83.24% lower than its most recent low trading price.
If we look at the average trading volume of 398.45K shares, AXGN reached to a volume of 1248646 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about AxoGen Inc. [AXGN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AXGN shares is $16.30 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AXGN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Cantor Fitzgerald have made an estimate for AxoGen Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on June 16, 2020. The new note on the price target was released on May 07, 2020, representing the official price target for AxoGen Inc. stock.
The Average True Range (ATR) for AxoGen Inc. is set at 0.74, with the Price to Sales ratio for AXGN stock in the period of the last 12 months amounting to 4.88. The Price to Book ratio for the last quarter was 4.36, with the Price to Cash per share for the same quarter was set at 2.59.
Trading performance analysis for AXGN stock
AxoGen Inc. [AXGN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 21.48. With this latest performance, AXGN shares gained by 15.59% in over the last four-week period, additionally plugging by 56.56% over the last 6 months – not to mention a drop of -7.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AXGN stock in for the last two-week period is set at 64.48, with the RSI for the last a single of trading hit 69.77, and the three-weeks RSI is set at 62.49 for AxoGen Inc. [AXGN]. The present Moving Average for the last 50 days of trading for this stock 11.59, while it was recorded at 11.99 for the last single week of trading, and 11.64 for the last 200 days.
AxoGen Inc. [AXGN]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and AxoGen Inc. [AXGN] shares currently have an operating margin of -27.12 and a Gross Margin at +83.74. AxoGen Inc.’s Net Margin is presently recorded at -27.30.
Return on Total Capital for AXGN is now -20.49, given the latest momentum, and Return on Invested Capital for the company is -20.75. Return on Equity for this stock declined to -20.88, with Return on Assets sitting at -18.51. When it comes to the capital structure of this company, AxoGen Inc. [AXGN] has a Total Debt to Total Equity ratio set at 2.52. Additionally, AXGN Total Debt to Total Capital is recorded at 2.46, with Total Debt to Total Assets ending up at 2.15. Long-Term Debt to Equity for the company is recorded at 1.21, with the Long-Term Debt to Total Capital now at 1.18.
Reflecting on the efficiency of the workforce at the company, AxoGen Inc. [AXGN] managed to generate an average of -$73,947 per employee. Receivables Turnover for the company is 6.61 with a Total Asset Turnover recorded at a value of 0.68.AxoGen Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 9.10 and a Current Ratio set at 10.00.
AxoGen Inc. [AXGN]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, AxoGen Inc. posted -0.07/share EPS, while the average EPS was predicted by analysts to be reported at -0.11/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 36.40%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AXGN.
An analysis of insider ownership at AxoGen Inc. [AXGN]
There are presently around $422 million, or 83.30% of AXGN stock, in the hands of institutional investors. The top three institutional holders of AXGN stocks are: ARROWMARK COLORADO HOLDINGS LLC with ownership of 6,726,309, which is approximately 6.275% of the company’s market cap and around 3.20% of the total institutional ownership; BLACKROCK INC., holding 2,879,003 shares of the stock with an approximate value of $37.77 million in AXGN stocks shares; and ESSEX WOODLANDS MANAGEMENT, INC., currently with $31.88 million in AXGN stock with ownership of nearly 0% of the company’s market capitalization.
Positions in AxoGen Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 73 institutional holders increased their position in AxoGen Inc. [NASDAQ:AXGN] by around 5,935,897 shares. Additionally, 43 investors decreased positions by around 6,643,279 shares, while 23 investors held positions by with 19,574,471 shares. The mentioned changes placed institutional holdings at 32,153,647 shares, according to the latest SEC report filing. AXGN stock had 24 new institutional investments in for a total of 1,945,971 shares, while 23 institutional investors sold positions of 6,153,390 shares during the same period.